Friday 6 November 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue: +21.8%
EPS: −80.6%
Free cash flow: +6.78%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

45.66 1.12 +2.51%

Follow ALKS

Alert me

Market cap: $7.5B
P/E: 0.0×
Fwd P/E: −85.9×
Dividend yield: —
F-score: 7/9
Altman Z: 5.33
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	4	3	2
ROE Full definition →		14.72%	9.36%	3.85%	(0.02%)
ROA Full definition →		10.64%	4.82%	1.99%	(0.01%)
ROIC Full definition →		31.75%	4.36%	2.76%	1.54%
Return on Tangible Assets Full definition →		15.03%	15.59%	6.13%	(0.03%)
Average Days of Receivables Full definition →		82.61	95.23	99.91	95.56
Free Cash Flow per Share Full definition →		2.92	1.33	1.33	1.36
Free Cash Flow Full definition →		481.42	221.18	222.71	228.43
Capital Expenditures Full definition →		(39.33)	(35.02)	(28.47)	(14.55)
Other line items
Cash ROIC Full definition →		15.34%	5.86%	5.61%	5.55%
Accounts Receivable Turnover Full definition →		4.11	4.30	4.11	4.31
Accounts Payable Turnover Full definition →		0.83	0.87	0.89	1.18
Inventory Turnover Full definition →		1.04	0.80	1.05	1.33
Average Days of Payables Full definition →		537.99	511.36	471.29	358.09
Days of Inventory on Hand Full definition →		365.31	588.48	423.78	317.54
Tax Rate Full definition →		(0.17)	(0.25)	(0.32)	(1.03)
Research and Development Expense of Revenue Full definition →		21.95%	22.75%	23.45%	24.55%
Selling, General and Administrative Expense of Revenue Full definition →		47.53%	50.85%	50.44%	50.06%
Share Based Compensation of Revenue Full definition →		6.69%	7.18%	7.10%	6.87%
Interest Coverage Full definition →		—	5.12	2.04	0.81
Operating CF/Net income Full definition →		2.15	1.68	3.80	(692.27)
Depreciation/Fixed assets Full definition →		0.12	0.24	0.48	0.71
Capex/Depreciation Full definition →		(1.45)	(0.67)	(0.27)	(0.09)
Revenue per Share Full definition →		8.96	9.40	9.98	10.45
Operating CF per Share Full definition →		3.16	1.54	1.50	1.45
Capex per Share Full definition →		(0.24)	(0.21)	(0.17)	(0.09)
Capex to Sales Full definition →		0.03	0.02	0.02	0.01

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly